Current Edition


Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

·         Optibrium, IFF and Intellegens’ joint peer-reviewed research published in Journal of Computer Aided Molecular Design ·         Study demonstrates accuracy and predictive capability of proprietary deep learning …

Continue Reading →
Disease Models

Benefits & Key Considerations of Using Human iPSC-Derived Disease Models in Drug Discovery

The process of drug discovery, development and commercialisation is long and associated with high costs. In addition, it is estimated that only 1% of the …

Continue Reading →
Drug Discovery

Optibrium Releases 3D Ligand-based Design Module for StarDrop Drug Discovery Software

Optibrium Ltd, a developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small …

Continue Reading →

CRISPR-Cas9 Knockout Screening Using Primary Human Cells in Drug Discovery

While significant progress has been made carrying out CRISPR screens in immortalised cell lines, a more physiological and clinically relevant alternative is human primary cells, …

Continue Reading →